HomeMBX • NASDAQ
add
MBX Biosciences Inc
Previous close
$13.69
Day range
$13.02 - $13.41
Year range
$13.02 - $27.50
Market cap
444.45M USD
Avg Volume
298.01K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 19.61M | 79.19% |
Net income | -18.14M | -78.53% |
Net profit margin | — | — |
Earnings per share | -2.78 | — |
EBITDA | -19.54M | -79.16% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 277.06M | — |
Total assets | 282.40M | — |
Total liabilities | 11.03M | — |
Total equity | 271.37M | — |
Shares outstanding | 33.42M | — |
Price to book | 1.68 | — |
Return on assets | -28.40% | — |
Return on capital | -30.05% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -18.14M | -78.53% |
Cash from operations | -14.66M | -89.80% |
Cash from investing | -100.79M | -441.73% |
Cash from financing | 235.81M | 244.27% |
Net change in cash | 120.36M | 185.45% |
Free cash flow | -8.90M | — |
About
Founded
2018
Headquarters
Website
Employees
38
